About Human Care Systems
Founded in 2008, Human Care Systems (HCS) delivers improved access, use, experience, and outcomes from medicines by helping patients better manage complex diseases and therapies. With a 10:1+ ROI, our patient support programs help top biopharmaceutical companies — from large to small — achieve improved therapy initiation and adherence, and an overall better patient experience on their brands.
Matt Hall, CEO, Human Care Systems (HCS). Matt founded HCS in 2008 to deliver systematic, evidence-driven solutions to improve real world health outcomes. HCS provides complete therapy support solutions to pharmaceutical companies globally. Prior to founding HCS, Matt co-founded the Kerdan Group, a biopharma and life science consulting firm. Matt has also run a healthcare information business, worked in venture capital and as a consultant at Bain & Company. He has lived and worked in Europe, Japan, South Africa and South Korea. Matt holds a bachelor’s degree with honors in Political Economy from Williams College.
Thom is President at Human Care Systems, where he leads interdisciplinary teams to satisfy the vision and business objectives of Human Care Systems’ clients and manages development of behavior-science based products and services. Prior to joining Human Care Systems, Thom was a Partner at the Kerdan Group, a biopharma and life science consulting firm, where he helped biotech and pharmaceutical clients with drug development strategies in diabetes, cardiovascular, ophthalmology, oncology, central nervous system and inflammatory diseases. Thom has also worked for Monitor Company in the US and Europe. He holds bachelor’s degrees in Economics and Chemical Engineering from the Massachusetts Institute of Technology.
Nancy Santilli is a Life Science Executive with a unique General Management background that blends her foundational clinical experience with strategic industry leadership (pharmaceutical, medical devices, practice management, EMR). She has an established track record of identifying new strategic opportunities, launching new products, building and supporting scientific and clinical platforms, and contributing to overall corporate growth.
Nancy was with Endo Health Solutions for more than nine years, holding roles that include multiple VP positions in Scientific Engagement, Scientific Affairs, Corporate Special Projects, Marketing Science, Strategic Planning, Commercial Strategy and Portfolio Planning, and Managed Markets. Prior to Endo, she was a Senior Director at Élan Pharmaceuticals in Global New Product Planning and Strategic Marketing, after joining the firm as an Associate Director in Marketing responsible for launching 4 CNS products. Earlier in her career, Ms. Santilli was with the University of Virginia School Of Medicine as an Associate Professor and the Associate Director, Comprehensive Epilepsy Program.
We work across disciplines and on tight deadlines to produce powerful, effective solutions that optimize distribution, clinician support, patient support, safety monitoring and support, and real-world evidence collection and use. We are diverse in our backgrounds and interests, but united in our natural empathy, our creative tendencies, and our passion to make a real difference for healthcare stakeholders.